Venus Remedies Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the BE series, faced a 5% price band on this day, which is the maximum allowed daily loss for the session. The closing price of Rs 1,833.5 represented a decline of Rs 96.5 from the previous close, triggering the lower circuit lock. This means that while sellers were eager to exit, buyers were absent, resulting in unfilled supply and a freeze in price movement. The total traded volume was 43,713 shares, with a turnover of approximately Rs 8.16 crore. Despite this turnover, the price remained locked at the floor, indicating that supply overwhelmed demand to the point where the circuit breaker intervened — how sustainable is this selling pressure and what does it imply for the stock’s near-term liquidity?

Delivery and Volume Analysis

Contrary to what might be expected in a typical sell-off, delivery volumes on 29 Jun 2026 fell by 35.68% compared to the 5-day average, with only 3,830 shares delivered. This decline in delivery volume suggests that the selling pressure may be driven more by speculative short-selling rather than genuine liquidation of holdings. On a lower circuit day, rising delivery volumes would indicate holders dumping actual positions, signalling capitulation or forced selling. However, in this case, the falling delivery volume points to a different dynamic — is this a temporary technical reaction or a sign of deeper weakness?

Intraday Price Action

The stock opened at Rs 1,930, trading near the previous close, but gradually declined throughout the session to hit the lower circuit at Rs 1,833.5. The intraday range of Rs 96.5 represents a 5.0% swing, exactly matching the price band limit. The weighted average price indicates that more volume traded close to the low price, reinforcing the dominance of sellers as the session progressed. This gradual descent rather than a sharp gap-down suggests persistent selling pressure rather than a sudden panic — does this steady decline point to a sustained downtrend or a controlled exit by traders?

Moving Averages and Trend Context

Interestingly, Venus Remedies Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This unusual configuration for a stock hitting its lower circuit suggests that the recent decline is somewhat isolated and not yet confirmed by longer-term trend indicators. Typically, a lower circuit hit accompanied by trading below all major moving averages would confirm a severe downtrend. Here, the technical picture is mixed, raising the question of whether the current selling pressure is a short-term event or the start of a broader correction — does the technical profile of Venus Remedies show any nearby support, or is more downside likely?

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately Rs 2,497 crore, Venus Remedies Ltd falls within the micro-cap segment. The stock’s liquidity profile is moderate, with a trade size of Rs 0.29 crore based on 2% of the 5-day average traded value. While this suggests some capacity for trading, the lower circuit lock highlights a critical exit risk for sellers. In micro-cap stocks, a lower circuit can trap sellers who find no buyers at the floor price, potentially leading to multi-day circuit locks and amplified exit friction — how deep is the exit problem for Venus Remedies and what would need to change for normal trading to resume?

Brief Fundamental Context

Operating in the Pharmaceuticals & Biotechnology sector, Venus Remedies Ltd has seen a recent underperformance relative to its sector, with a 1-day sector gain of 0.78% contrasting with the stock’s 5.0% loss. The stock has also recorded a consecutive two-day decline, falling 5.83% over this period. These figures suggest that the current weakness is largely stock-specific rather than driven by broader sector or market trends.

Conclusion: Severity Assessment and Liquidity Caveats

The 5.0% lower circuit lock on Venus Remedies Ltd reflects a session where supply overwhelmed demand to the extent that the exchange halted further price declines. The falling delivery volume suggests speculative short-selling rather than widespread holder capitulation, which may moderate the severity of the move. However, the micro-cap status and moderate liquidity profile mean that sellers face tangible exit risks, as unfilled supply at the circuit floor can persist for multiple sessions. The stock’s position above all major moving averages adds complexity to the technical picture, indicating that the current weakness may not yet be entrenched in the longer-term trend. After a 5.0% single-day loss at lower circuit, is Venus Remedies approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today